76 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
assets
Property and equipment, net
Right-of-use asset
Intangible assets, net
Restricted cash
Other long-term assets
Total assets
Liabilities … liabilities
Long-term liabilities:
Other long-term liabilities
Lease liability
Derivative liability
Total liabilities
Stockholders’ equity:
Preferred Stock
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
in patients with hypothalamic obesity (n=12) who transitioned to long term extension from Ph 2 trial; three of 11 pediatric patients achieving normal body … with severe obesity caused by rare MC4R pathway diseases. Long-term extension study data in patients with hypothalamic obesity (n=12) demonstrate a 25.5
8-K
EX-99.1
z83mut2m
1 Aug 23
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business
7:05am
8-K
EX-99.1
tpc7msmbk1
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
q1gns5jhoc
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am
8-K
EX-1.1
hz5q07w4k 9o52eljt
15 Sep 22
Other Events
4:02pm
424B5
olsk6q84jpx
15 Sep 22
Prospectus supplement for primary offering
4:00pm
424B5
stj66s55fsoiu ulh83
14 Sep 22
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
l54c20xfti6
2 Aug 22
Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
7:02am
8-K
EX-99.1
g8t1us03f yk
3 May 22
Rhythm Pharmaceuticals Reports First Quarter 2022 Financial Results and Business Update
7:05am